| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
On November 3, 2025, The Oncology Institute, Inc. (the "Company") determined that a cybersecurity incident affecting an information technology software provider would potentially delay fee-for-service collections. Based on the Company's current assessment, this incident is expected to result in a brief immaterial delay in the collection of some claims in the Company's fee-for-service segment.
To date, the software provider has not indicated to the Company that there is any evidence that any patient personal information was compromised as a result of this incident, and an investigation remains ongoing.
The Company is collaborating closely with the software provider to mitigate the effects and restore normal billing operations as quickly as possible.
Posted In: TOI
